Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- University of Minnesota
- Rutgers University
- Stanford University
- UNIVERSITY OF HELSINKI
- University of Florida
- University of Washington
- Baylor College of Medicine
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Icahn School of Medicine, CABCT
- Indiana University
- Institut de l'Audition/Institut Pasteur
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- McGill University
- Nencki Institute of Experimental Biology
- Northeastern University
- RCSI - Royal College of Surgeons in Ireland
- Research Center for Molecular Medicine (CeMM), ÖAW
- The Ohio State University
- The University of Arizona
- Umeå universitet stipendiemodul
- University Hospital Magdeburg
- University of Kansas Medical Center
- University of Maryland, Baltimore
- University of Nebraska Medical Center
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- University of Texas at Tyler
- 18 more »
- « less
-
Field
-
Research Center for Molecular Medicine (CeMM), ÖAW | Vienna, Virginia | United States | about 2 months ago
functional approaches to map how leukemia-driving oncoproteins act in the context of phase-separated biomolecular condensates and how these structures regulate epigenetic states and cancer-associated gene
-
Class Acad Prof and Admin Add to My Favorite Jobs Email this Job About the Job The overall objective of the lab is to understand the mechanisms modulating resistance to therapy and use the knowledge
-
submit manuscripts and research grants. The overall focus of this post-doctoral research position is the development of self renewable human induced pluripotent stem cell (iPSC)-based therapies
-
Dr. Vincenzo Calvanese. RESEARCH DESCRIPTION Hematopoietic stem cells (HSC) are a life-saving therapy for leukemia, and have found broadened applications in gene and cell therapy against other cancers
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
-specific knowledge: A strong base of knowledge in signal transduction, genome maintenance, DNA replication, cell cycle, and how these processes impact carcinogenesis and cancer therapy. Research methods
-
development of T cell therapy for cancer, including tumor-infiltrating lymphocytes and gene engineered T cells. Prepares written reports of the research experiments. Prepares grant proposals based
-
of the pathophysiology of neurodegenerative diseases and to identify novel pathways and targets for the development of therapy. In particular, we are interested in understanding the mechanisms underlying protein
-
genetically modified mice, performs stereotaxic brain surgeries to delivery gene therapy through viral vectors or recombinant proteins, analyzes brains using morphological and biochemical assays including
-
, cell culture, gene knock-down via siRNA/shRNA). Demonstrated research productivity evidenced by first-author publications in peer-reviewed journals. Preferred Qualifications: Experience in prostate
-
. Specific training and accreditation for experimental animal work. Knowledge of neuromuscular disorders, muscular dystrophies, regenerative medicine, gene/cell therapy or translational research. Fluency in